Aflac (AFL) to Release Quarterly Earnings on Wednesday

Aflac (NYSE:AFL - Get Free Report) is expected to post its Q1 2025 quarterly earnings results after the market closes on Wednesday, April 30th. Analysts expect the company to announce earnings of $1.69 per share and revenue of $4.53 billion for the quarter.

Aflac (NYSE:AFL - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, analysts expect Aflac to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Aflac Price Performance

NYSE:AFL traded up $0.59 during trading hours on Monday, hitting $108.53. The stock had a trading volume of 311,258 shares, compared to its average volume of 1,979,342. Aflac has a one year low of $80.59 and a one year high of $115.50. The company has a 50 day simple moving average of $107.14 and a two-hundred day simple moving average of $107.07. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. The firm has a market capitalization of $59.24 billion, a price-to-earnings ratio of 11.31, a P/E/G ratio of 3.24 and a beta of 0.81.

Insider Buying and Selling at Aflac

In other news, Director Joseph L. Moskowitz sold 1,000 shares of the business's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the completion of the transaction, the director now directly owns 25,393 shares of the company's stock, valued at $2,733,048.59. The trade was a 3.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Charles D. Lake II sold 29,802 shares of the firm's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the sale, the director now owns 49,962 shares in the company, valued at $5,360,422.98. This represents a 37.36 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.90% of the company's stock.

Institutional Investors Weigh In On Aflac

A hedge fund recently raised its stake in Aflac stock. Brighton Jones LLC raised its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 64.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,570 shares of the financial services provider's stock after buying an additional 5,708 shares during the period. Brighton Jones LLC's holdings in Aflac were worth $1,507,000 at the end of the most recent quarter. 67.44% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

AFL has been the topic of several research reports. Wells Fargo & Company lowered their price objective on shares of Aflac from $104.00 to $102.00 and set an "equal weight" rating on the stock in a research report on Wednesday, February 19th. Barclays dropped their price objective on Aflac from $98.00 to $95.00 and set an "underweight" rating for the company in a report on Friday, February 7th. UBS Group boosted their price objective on shares of Aflac from $109.00 to $114.00 and gave the company a "neutral" rating in a research report on Wednesday, April 2nd. Piper Sandler boosted their price target on shares of Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a research report on Wednesday, April 2nd. Finally, Morgan Stanley lowered their price objective on shares of Aflac from $105.00 to $100.00 and set an "equal weight" rating for the company in a report on Thursday, April 10th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $103.93.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.